Indutrade acquires the Italian medtech company SLT

2025-07-31

Indutrade has signed an agreement to acquire all shares in the Italian company SLT srl, www.sltsrl.com, with annual sales of approximately EUR 7.5 million (SEK 85 million).

SLT is a technical trading company offering testing and safety control devices for the medical technology and healthcare sectors. The company specialises in products for safety and performance verification of medical equipment and bioimaging, complemented with calibration services and training programs. Customers include OEM’s which produce medical equipment, global service providers and hospitals. SLT was founded in 1949, has 19 employees and is located in Milan, Italy.

“SLT has a leading market position in a well-defined niche and a unique offering built on high technical know-how. We welcome SLT and its team to Indutrade”, said Bo Annvik, President and CEO of Indutrade.

The closing is expected to be finalised during Q3 2025. SLT will be included in Indutrade's Business Area Life Science. The acquisition is Indutrade's fifth in 2025 and is expected to have a marginally positive impact on Indutrade's earnings per share.

About Indutrade
Indutrade is an international technology and industrial business group that today consists of over 200 companies in some 30 countries, mainly in Europe. In a decentralised way, we aim to provide sustainable profitable growth by developing and acquiring successful companies managed by passionate entrepreneurs. Our companies develop, manufacture, and sell components, systems and services with significant technical content in selected niches. Our value-based culture, where people make the difference, has been the foundation of our success since the start in 1978. Indutrade's net sales totalled SEK 32.5 billion in 2024, and the share is listed on Nasdaq Stockholm in Sweden.

Downloads